Assessing the Right Heart Remodeling After Transcatheter Tricuspid Edge-to-edge Repair

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-15

Study Completion Date

2025-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the recent years, secondary tricuspid regurgitation (STR) has gained interest due to its high prevalence and impact on outcomes. Transcatheter tricuspid valve replacement or repair represents novel and less invasive alternatives to surgery and has shown early promising results. Treatment options mimic surgical techniques such as leaflet approximation, direct annuloplasty, and heterotopic caval valve implantation, as well as not yet commercially available transcatheter TV replacement systems using orthotopic valve implantation. (5) Among leaflet approximation techniques, the Tricuspid transcatheter edge-to-edge repair (T-TEER) using the TriClip™ (Abbott Vascular, Santa Clara, CA, USA) or leaflet approximation with the PASCAL systems (Edwards Lifesciences, Irvine, CA, USA) are approved in Europe for minimally invasive TV repair.The purposes of the present study are: i. to use 3DE and CCT to evaluate the effect of T-TEER on the geometry and function of the right heart chambers in patients with STR; ii. to identify the predictors of procedural success potentially related to features of both right chambers geometry and TR jet; iii. to compare the accuracy of 3DE assessment of the right ventricle, the right atrium, and the tricuspid annulus, with the same parameters obtained by CCT, in the setting of T-TEER; and iv. to assess patients' outcome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Surgical Treatment of Tricuspid Valve Regurgitation in Patients With Cardiac Implantable Electronic Devices: Long Term Results

NCT05774821

Tricuspid Regurgitation

COMPLETED

Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach

NCT03278418

Tricuspid Valve Insufficiency

UNKNOWN NA

TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System

NCT02981953

Tricuspid Valve Insufficiency Tricuspid Regurgitation Tricuspid Valve Regurgitation +4 more

COMPLETED NA

Cardiac Implantable Electronic Device- Induced Remodelling of Tricuspid Valve and Right Chambers

NCT06914570

Cardiac Pacing, Artificial Tricuspid Valve Regurgitation, Non-rheumatic

RECRUITING

Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve

NCT04500964

Failed Transcather Aortic Valve

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tricuspid Regurgitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tricuspid transcatheter edge-to-edge repair

Transcatheter tricuspid leaflets approximation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age\> 18 years
* Severe STR, amenable to percutaneous treatment with T-TEER
* Acceptance to be part of this study by signing the informed consent
* Good enough acoustic window and ability to cooperate in order to obtain 3D echo data sets of cardiac structures with a minimum temporal resolution of 20 fps
* Availability for clinical, CCT and, echocardiography follow-up visits

Exclusion Criteria

* Pregnancy
* Severe chronic kidney disease (GFR \<30 mL/min)
* Hypersensitivity reactions to contrast media
* Cardiovascular implantable electronic device-related (CIED) tricuspid regurgitation.
* Bad acoustic window with inadequate echocardiographic images.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No